Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients with 24 manufacturing sites and 7 R&D centers in Europe, North America and Asia.
Location: France, Auvergne-Rhone-Alpes, Écully
Investors 3
| Date | Name | Website |
| - | Merieux De... | merieux-pa... |
| - | Ardian | ardian.com |
| - | Eurazeo | eurazeo.co... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 17.12.2021 | Change in SEQENS' Shareholding Structure – SEQENS Is Now Str... | SEQENS is pleased to announce that, on December 16, 2021, funds advised by SK Capital have become th... | marketscre... |
| 27.08.2021 | Five years after its entry into the capital of SEQENS, Euraz... | PRESS RELEASE | ECULLY, FRANCE – August 26th, 2021 Eurazeo today announced that it has entered into... | skcapitalp... |